| Ol (lots) | Call Price | Strike Price | Put Price | Ol (lots) |
|---|---|---|---|---|
| 3,5000% | ₹502.25 0% | 3,100 | ₹1.4 0% | 4,0000% |
| - | - | 3,200 | ₹0.5 0% | 1,0000% |
| - | - | 3,250 | ₹1.4 40% | 4,250-10.52% |
| 1,0000% | ₹287.3 0% | 3,300 | ₹1.7 -5.55% | 73,250142.14% |
| 1,0000% | ₹242.15 0% | 3,350 | ₹2.85 -22.97% | 29,750-16.78% |
| 4,5000% | ₹177.2 -0.19% | 3,400 | ₹2.7 -15.62% | 34,750-13.66% |
| 5,00066.66% | ₹165.15 23.56% | 3,450 | ₹3.4 -54.36% | 23,250-33.57% |
| 87,750-2.22% | ₹118.3 29.21% | 3,500 | ₹5.3 -43.61% | 1,29,25019.39% |
| 1,19,250-2.25% | ₹76.55 54.64% | 3,550 | ₹11 -51.96% | 60,50037.5% |
| 1,14,500-16.57% | ₹39.25 60.86% | 3,600 | ₹25.85 -43.8% | 43,25036.22% |
| 48,5007.77% | ₹17.95 56.08% | 3,650 | ₹54 -38.17% | 13,750-1.78% |
| 96,75016.21% | ₹7.6 42.05% | 3,700 | ₹95.8 -28.72% | 6,5000% |
| 52,00061.24% | ₹2.8 -20% | 3,750 | ₹144.85 -14.16% | 9,75044.44% |
| 48,250-2.03% | ₹2.45 11.36% | 3,800 | ₹191.4 -14.13% | 5,0005.26% |
| 34,2502.23% | ₹1.65 -2.94% | 3,850 | ₹331 0% | 1,2500% |
| 27,75050% | ₹1.3 -29.72% | 3,900 | ₹313.6 0% | 1,5000% |
| 10,5000% | ₹1.8 12.5% | 3,950 | ₹430.05 0% | 7,7500% |
| 35,500-27.55% | ₹0.5 -60% | 4,000 | ₹411 0% | 1,0000% |
| 19,750-14.13% | ₹0.55 -35.29% | 4,100 | ₹533.3 0% | 10,7500% |
| 8,000-3.03% | ₹0.3 -60% | 4,200 | ₹677.4 0% | 6,0000% |
Torrent Urja, is a wholly owned subsidiary of Torrent Green Energy Pvt. Ltd. The company is incorporated to develop a solar-plus-wind power project.
The transaction involves around 38.75 lakh shares, priced at ₹1,600 each, being offloaded by JB Chemicals employees who recently converted their stock options.
The acquisition values JB Chemicals at ₹25,689 crore on a fully diluted basis, according to the company’s official announcement.
On the operating front, EBITDA for the quarter was reported at ₹964 Crore. It was 9.20% higher than ₹883 in Q4FY24.
Here are some of the stocks that may see significant price movement today: JK Cement, KEC International, Macrotech Developers, etc.
Empagliflozin is a new sodium-glucose co-transporter-2 (SGLT-2) inhibitor approved for glycemic management in individuals with type 2 diabetes.
The USFDA examined Torrent's manufacturing plant in Pithampur during the September quarter and issued a Form 483 with one observation.
The business reported a 13% growth in India revenues to ₹1,632 Crore, driven by outperformance in focus therapies.
When compared to the previous quarter, revenue growth was modest at 1.05%, while net profits experienced a slight decline of 0.88%.
In August, the CDSCO banned more than 156 fixed-dose combination medications from the Indian market.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
